Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WCG Appoints Sam Srivastava CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

WCG Appoints Sam Srivastava CEO

Srivastava will oversee all WCG global operations leveraging his 30 years of experience in the healthcare industry.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WCG, a provider of solutions to improve the quality and efficiency of clinical research, has appointed Sam Srivastava as Chief Executive Officer. Srivastava joins the company from NeueHealth, a tech enabled risk bearing care delivery company, where he also served as CEO. He succeeds Dr. Donald Deieso, upon his retirement.
 
Srivastava will oversee all WCG global operations. In a career spanning 30 years, Srivastava has been a recognized thought leader and strategist in the healthcare industry. Prior to NeueHealth, he held executive leadership roles for companies including Bright Health, Magellan Healthcare, Cigna, and United Health Group.
 
“Joining WCG at this pivotal moment in their growth and transformation is an honor,” said Srivastava. “The clinical trials industry is in need of disruption, and WCG is the only company in the market with the solutions, data, technology, and expertise to make it happen. We are in a unique position to drive the advancement needed throughout the clinical trials ecosystem to enable the delivery of better healthcare. I’m excited to join this trailblazing team and lead this innovative strategy.”
 
“As WCG continues to shape the clinical trials sector, I am excited that Sam, a recognized and respected industry leader with deep expertise and an exceptional track record, will be leading the WCG team. His unique perspectives and expertise in strategy, development, integration, and operations will drive deeper awareness and preference for WCG’s differentiated solutions with our rapidly expanding network of customers and partners while also strengthening our market position,” said Dr. Deieso.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics